Home
Krebs Biochemicals & Industries Ltd EPS

Krebs Biochemicals & Industries Ltd
NSE: KREBSBIO
EPS
Key Highlights
- The Earning per Share of Krebs Biochemicals & Industries Ltd is ₹ -12.57 as of 17 Sep 25 .
- The earning per share of Krebs Biochemicals & Industries Ltd changed from ₹ -2.47 to ₹ -2.47 over 9 quarters. This represents a CAGR of 0.00% .
Historical Earning per Share of Krebs Biochemicals & Industries Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Krebs Biochemicals & Industries Ltd
Company Fundamentals for Krebs Biochemicals & Industries Ltd
Market Cap
170 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
0.0
Day’s High
81.49
Day’s Low
76.0
DTE
-1.5
ROE
18.4
52 Week High
129.0
52 Week Low
63.55
ROCE
-18.5
Market Price of Krebs Biochemicals & Industries Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
17 Sep 2025 | 79.1 |
16 Sep 2025 | 78.75 |
15 Sep 2025 | 75 |
12 Sep 2025 | 77.26 |
11 Sep 2025 | 77.63 |
10 Sep 2025 | 75.85 |
09 Sep 2025 | 72.75 |
08 Sep 2025 | 73.12 |
05 Sep 2025 | 74 |
04 Sep 2025 | 72.67 |
SWOT Analysis Of Krebs Biochemicals & Industries Ltd
BlinkX Score for Krebs Biochemicals & Industries Ltd
Asset Value vs Market Value of Krebs Biochemicals & Industries Ltd
Market Value
₹ 171
Asset Value
Value addition
15.6 X
₹ 10
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Krebs Biochemicals & Industries Ltd | 170.54 | - |
Sun Pharmaceutical Industries Ltd | 388752 | 47.81 |
Divis Laboratories Ltd | 160626 | 86.87 |
Cipla Ltd | 125949 | 66.76 |
Torrent Pharmaceuticals Ltd | 119926 | 59.67 |
Dr Reddys Laboratories Ltd | 109413 | 68.07 |
Company | |
---|---|
Krebs Biochemicals & Industries Ltd | 170.54 |
Sun Pharmaceutical Industries Ltd | 388752 |
Divis Laboratories Ltd | 160626 |
Cipla Ltd | 125949 |
Torrent Pharmaceuticals Ltd | 119926 |
Dr Reddys Laboratories Ltd | 109413 |
Historical Market Cap of Krebs Biochemicals & Industries Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Krebs Biochemicals & Industries Ltd
Historical Revenue of Krebs Biochemicals & Industries Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Krebs Biochemicals & Industries Ltd
Historical EBITDA of Krebs Biochemicals & Industries Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Krebs Biochemicals & Industries Ltd
Historical Net Profit of Krebs Biochemicals & Industries Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Krebs Biochemicals & Industries Ltd
Dividend Payout Over Time
Krebs Biochemicals & Industries Ltd News Hub
Krebs Biochemicals & Industries reports standalone net loss of Rs 5.17 crore in the June 2024 quarter
Net Loss of Krebs Biochemicals & Industries reported to Rs 5.17 crore in the quarter ended June 2024
Read more
07 Aug 24
Krebs Biochemicals & Industries schedules AGM
Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of the company
Read more
09 Sept 24
Krebs Biochemicals & Industries to conduct board meeting
Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 11 N
Read more
29 Oct 24
Krebs Biochemicals & Industries reports standalone net loss of Rs 5.76 crore in the September 2024 quarter
Net Loss of Krebs Biochemicals & Industries reported to Rs 5.76 crore in the quarter ended September
Read more
11 Nov 24